[1]
“Bioabsorbable Vascular Scaffolds Eluting with Everolimus: for Percutaneous Coronary Intervention of Patients with de-novo Coronary Artery Lesion: Our Experiences at a Tertiary Hospital”, Cardiovasc. j., vol. 6, no. 2, pp. 122–126, Mar. 2014, doi: 10.3329/cardio.v6i2.18352.